Published in Ann Intern Med on August 21, 2001
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06
Benefits of progestin contraception in non-allergic angioedema. Clin Exp Allergy (2013) 1.49
Efficacy of icatibant treatment in patients with hereditary angio-oedema type I resistant to treatment with C1 inhibitor concentrate. Br J Dermatol (2011) 1.40
Comparative in-vitro activity of ciprofloxacin against non-fermenters. J Antimicrob Chemother (1985) 1.28
Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy (2010) 1.05
[Diagnostic delay in Horton's disease. Analysis of the diagnostic delay based on a retrospective study of 130 cases]. Rev Med Interne (1992) 0.95
Anaphylactic reaction to ranitidine and dexchlorpheniramine. Eur J Dermatol (2007) 0.94
Evidence for various calcium sites in human hair shaft revealed by sub-micrometer X-ray fluorescence. Biochim Biophys Acta (2003) 0.90
Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmun Rev (2011) 0.89
Safety and efficacy of icatibant self-administration for acute hereditary angioedema. Clin Exp Immunol (2012) 0.88
A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene. Br J Dermatol (2007) 0.86
[Frosted-branch angiitis revealing Behçet's disease]. J Fr Ophtalmol (2009) 0.86
[Acute respiratory distress syndrome as the presenting manifestation of an antisynthetase syndrome]. Rev Med Interne (2008) 0.84
[Management of angiotensin-converting enzyme inhibitor-related angioedema: recommendations from the French National Center for Angioedema]. Rev Med Interne (2013) 0.83
[New targets of antiphospholipid antibodies]. Rev Med Interne (1997) 0.83
[Congenital dyskeratosis or Zinsser-Cole-Engman dyskeratosis. A probable female case]. Presse Med (1995) 0.82
Challenges of C1-inhibitor concentrate self-administration. Int Arch Allergy Immunol (2013) 0.80
Effects of fish oil fatty acids on plasma lipids and lipoproteins and oxidant-antioxidant imbalance in healthy subjects. Scand J Clin Lab Invest (1999) 0.80
Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study. Allergy (2013) 0.78
Hepatitis C virus NS3 serine protease interacts with the serpin C1 inhibitor. FEBS Lett (1999) 0.78
[Severe hyperhomocysteinemia revealing homocystinuria in two young adults with mild phenotype]. Rev Med Interne (2005) 0.77
In vitro activity of pefloxacin. Drugs Exp Clin Res (1986) 0.76
Biological autoimmunity screening in hepatitis C patients by anti-HepG2 lysate and anti-heat shock protein 70.1 autoantibodies. Eur J Clin Microbiol Infect Dis (2008) 0.76
[Uveitis after the age of 60]. Rev Med Interne (2000) 0.76
Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients. Clin Exp Immunol (2014) 0.75
[Erythrocyte aggregation and its repercussions on conjunctival microcirculation in man. Morphometric study and biological correlates]. J Mal Vasc (1986) 0.75
[Erysipelothrix rhusiopathiae endocarditis with atrioventricular fistula]. Ann Med Interne (Paris) (1994) 0.75
[Iatrogenic angioedema due to estrogen, angiotensin conversion enzyme inhibitors, angiotensin receptor antagonists and dialysis membranes]. Rev Med Interne (2006) 0.75
[Cutaneous vasculitis revealing sarcoidosis: an unusual presentation]. Rev Med Interne (2003) 0.75
[Abdominal pain in a 44-year-old woman]. Rev Med Interne (2010) 0.75
MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing. J Frailty Aging (2016) 0.75
[Therapeutic intensification and autologous stem cell transplantation in autoimmune diseases]. Presse Med (2005) 0.75
Cutaneous adverse drug reaction to oral acetazolamide and skin tests. Dermatology (2013) 0.75
[Somatoform disorders. Analysis of 43 patients in an unit of internal medicine. Diagnostic attitude and proposal of management]. Ann Med Interne (Paris) (1993) 0.75
[Pneumocystis pneumonia complicated by infectious mononucleosis: an infrequent association]. Rev Med Interne (1999) 0.75
Mesalazine and para-phenylenediamine allergy. Contact Dermatitis (2004) 0.75
[Drug-induced eruption after treatment of hyperkeratotic crusted scabies with ivermectin]. Rev Med Interne (2004) 0.75
[Study of in vitro activity of 3 cephalosporins and their combination with 2 beta-lactamase inhibitors against 4 enterobacteria strains producing extended spectrum beta-lactamase]. Pathol Biol (Paris) (1997) 0.75
[Immunoallergic reaction with hepatitis induced by minocycline]. Ann Med Interne (Paris) (1998) 0.75
[Angiotensin converting enzyme inhibitor induced angioedema: a collateral damage?]. Rev Med Interne (2013) 0.75
[Vogt-Koyanagi-Harada syndrome: a serious and rare emergency in children]. Arch Pediatr (2010) 0.75
[Bronchopleural fistula after radiation therapy for a lung cancer]. Rev Med Interne (2004) 0.75
[Endotracheal prosthesis treatment of upper respiratory manifestations of atrophic polychondritis]. Presse Med (2002) 0.75
[Tuberous sclerosis without mental impairment, diagnosed in adulthood]. Rev Med Interne (2005) 0.75
[Chronic venous insufficiency and microcirculation. Physiopathologic and therapeutic reflections]. J Mal Vasc (1987) 0.75
[Management of bradykinin-mediated angioedema]. Ann Fr Anesth Reanim (2011) 0.75
[Diagnostic strategy in uveitis: a prospective study in 125 cases]. J Fr Ophtalmol (2000) 0.75
[Recurrent hypoglycemia in a 68-year-old man]. Rev Med Interne (2009) 0.75